Clioquinol and Pyrrolidine Dithiocarbamate as Cancer Treatments
Author Information
Author(s): Daniel Kenyon G, Chen Di, Orlu Shirley, Cui Qiuzhi Cindy, Miller Fred R, Dou Q Ping
Primary Institution: Barbara Ann Karmanos Cancer Institute, Wayne State University
Hypothesis
Can clioquinol and pyrrolidine dithiocarbamate interact with copper to form proteasome inhibitors and induce apoptosis in human breast cancer cells?
Conclusion
Clioquinol and pyrrolidine dithiocarbamate can target copper in breast cancer cells to induce apoptosis without harming normal cells.
Supporting Evidence
- Clioquinol and pyrrolidine dithiocarbamate can inhibit proteasome activity in breast cancer cells.
- These compounds induce apoptosis in malignant breast cancer cells but not in normal cells.
- Copper is required for the effectiveness of these compounds in inducing apoptosis.
Takeaway
Some medicines can work better on cancer cells because they can grab onto copper that cancer cells have a lot of, making them die while leaving normal cells safe.
Methodology
Breast cancer cell lines were treated with clioquinol or pyrrolidine dithiocarbamate with or without copper, followed by measurement of proteasome inhibition and cell death.
Limitations
The study primarily used immortalized breast cancer cell lines rather than true normal primary cell lines.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website